The Liddy Shriver Sarcoma Initiative helping those dealing with sarcoma.                      HOME

Liddy's Story
Sarcomas
Clinical Trials
ESUN
Funded Research
Sarcoma Calendar
Initiatives
Personal Journeys
Links
News
Donations
Volunteer
First Time Visitors
Searching Our Website
Guest Book
Unknown Effect
Up
Bevacizumab
ET-743
ImmTher
Immunotherapy
mTOR Inhibitors
Perifosine
TRM (TRAIL)

TRM (TRAIL)

Background Information  

  • Manufactured by Human Genome Sciences

  • Background science information

  • The TRAIL (tumor necrosis factor related apoptosis-inducing ligand) Receptor-1 protein was discovered by Human Genome Sciences. TRAIL Receptor-1 human monoclonal antibody (TRAIL-R1 mAb) specifically recognizes the TRAIL Receptor-1 protein, found on the surface of a number of solid tumor and hematopoietic cancer cells. TRAIL-R1 mAb mimics the activity of native TRAIL. As such, it is considered an agonistic antibody. Binding of TRAIL-R1 mAb to TRAIL Receptor-1 triggers cell death."

Research Results 

  • 2002 poster on in vitro and in vivo anti-tumor activity

  • 2002 press release for the above talk (easier to understand)

  • 2001 abstract stating that apoptosis (cell death) was induced in 7/9 Ewing's sarcoma cell lines by TRAIL (Note: these are cell line results)